Ardent Health [ARDT] vs Guardian Pharmacy [GRDN] Detailed Stock Comparison
Ardent Health
NYSE
Loading...
Guardian Pharmacy
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Ardent Health wins in 14 metrics, Guardian Pharmacy wins in 4 metrics, with 0 ties. Ardent Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ardent Health | Guardian Pharmacy | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 7.02 | 90.13 | Ardent Health |
| Price-to-Book Ratio | 1.51 | 11.06 | Ardent Health |
| Debt-to-Equity Ratio | 138.17 | 22.18 | Guardian Pharmacy |
| PEG Ratio | 0.10 | -6.39 | Guardian Pharmacy |
| EV/EBITDA | 6.90 | -52.89 | Guardian Pharmacy |
| Profit Margin (TTM) | 4.11% | -5.19% | Ardent Health |
| Operating Margin (TTM) | 8.34% | 4.38% | Ardent Health |
| EBITDA Margin (TTM) | 8.34% | 4.38% | Ardent Health |
| Return on Equity | 24.32% | -52.74% | Ardent Health |
| Return on Assets (TTM) | 5.61% | -10.92% | Ardent Health |
| Free Cash Flow (TTM) | $127.52M | $41.59M | Ardent Health |
| 1-Year Return | -27.66% | 66.99% | Guardian Pharmacy |
| Price-to-Sales Ratio (TTM) | 0.31 | 1.41 | Ardent Health |
| Enterprise Value | $4.02B | $1.95B | Ardent Health |
| EV/Revenue Ratio | 0.65 | 1.47 | Ardent Health |
| Gross Profit Margin (TTM) | 83.55% | 19.79% | Ardent Health |
| Revenue per Share (TTM) | $44 | $21 | Ardent Health |
| Earnings per Share (Diluted) | $1.89 | $-1.48 | Ardent Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Ardent Health vs Guardian Pharmacy Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ardent Health | -1.43% | -0.61% | 4.89% | -3.47% | -1.95% | -22.37% |
| Guardian Pharmacy | -2.18% | 5.07% | 31.03% | 46.30% | 53.10% | 49.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ardent Health | -27.66% | -24.10% | -24.10% | -24.10% | -24.10% | -24.10% |
| Guardian Pharmacy | 66.99% | 66.99% | 66.99% | 66.99% | 66.99% | 66.99% |
News Based Sentiment: Ardent Health vs Guardian Pharmacy
Ardent Health
News based Sentiment: POSITIVE
Ardent Health delivered a strong Q2 and reaffirmed its positive financial outlook for the full year. Active participation in investor conferences and continued expansion efforts demonstrate a commitment to growth and transparency, making this a significant month for the company and its investors.
Guardian Pharmacy
News based Sentiment: POSITIVE
September brought a wave of positive news for Guardian Pharmacy Services, including analyst upgrades, institutional investment, and new 52-week highs. While the company's lack of current profitability remains a concern, the overall trend suggests growing investor confidence and potential for future growth. The upcoming conference participation will be a key event to watch.
Performance & Financial Health Analysis: Ardent Health vs Guardian Pharmacy
| Metric | ARDT | GRDN |
|---|---|---|
| Market Information | ||
| Market Cap | $1.87B | $1.88B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 258,260 | 359,815 |
| 90 Day Avg. Volume | 359,843 | 288,262 |
| Last Close | $13.08 | $29.64 |
| 52 Week Range | $10.10 - $20.72 | $14.16 - $30.39 |
| % from 52W High | -36.87% | -2.47% |
| All-Time High | $20.72 (Oct 14, 2024) | $30.39 (Sep 12, 2025) |
| % from All-Time High | -36.87% | -2.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.15% |
| Quarterly Earnings Growth | 0.71% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.05% |
| Operating Margin (TTM) | 0.08% | 0.04% |
| Return on Equity (TTM) | 0.24% | -0.53% |
| Debt to Equity (MRQ) | 138.17 | 22.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.77 | $2.68 |
| Cash per Share (MRQ) | $3.83 | $0.30 |
| Operating Cash Flow (TTM) | $301.98M | $57.66M |
| Levered Free Cash Flow (TTM) | $19.78M | $87.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ardent Health vs Guardian Pharmacy
| Metric | ARDT | GRDN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 7.02 | 90.13 |
| Forward P/E | 6.64 | 34.07 |
| PEG Ratio | 0.10 | -6.39 |
| Price to Sales (TTM) | 0.31 | 1.41 |
| Price to Book (MRQ) | 1.51 | 11.06 |
| Market Capitalization | ||
| Market Capitalization | $1.87B | $1.88B |
| Enterprise Value | $4.02B | $1.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.65 | 1.47 |
| Enterprise to EBITDA | 6.90 | -52.89 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $8.77 | $2.68 |
Financial Statements Comparison: Ardent Health vs Guardian Pharmacy
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ARDT | GRDN |
|---|---|---|
| Revenue/Sales | $1.50B | $329.31M |
| Cost of Goods Sold | $258.86M | $264.96M |
| Gross Profit | $1.24B | $64.35M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $67.09M | $13.01M |
| EBITDA | $124.58M | $18.54M |
| Pre-Tax Income | $74.20M | $13.11M |
| Income Tax | $15.23M | $3.83M |
| Net Income (Profit) | $58.97M | $9.27M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ARDT | GRDN |
|---|---|---|
| Cash & Equivalents | $495.04M | $14.00M |
| Total Current Assets | $1.76B | $166.04M |
| Total Current Liabilities | $830.14M | $145.30M |
| Long-Term Debt | $2.26B | $21.79M |
| Total Shareholders Equity | $1.56B | $163.22M |
| Retained Earnings | $407.18M | $26.57M |
| Property, Plant & Equipment | $2.06B | $78.92M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ARDT | GRDN |
|---|---|---|
| Operating Cash Flow | $21.34M | $20.61M |
| Capital Expenditures | $-22.91M | $-5.81M |
| Free Cash Flow | $-47.70M | $11.75M |
| Debt Repayment | $-1.39M | $-1.13M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ARDT | GRDN |
|---|---|---|
| Shares Short | 2.18M | 339,162 |
| Short Ratio | 5.74 | 1.41 |
| Short % of Float | 0.07% | 0.03% |
| Average Daily Volume (10 Day) | 258,260 | 359,815 |
| Average Daily Volume (90 Day) | 359,843 | 288,262 |
| Shares Outstanding | 142.75M | 63.29M |
| Float Shares | 24.47M | 19.45M |
| % Held by Insiders | 0.23% | 0.15% |
| % Held by Institutions | 0.74% | 0.83% |
Dividend Analysis & Yield Comparison: Ardent Health vs Guardian Pharmacy
| Metric | ARDT | GRDN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |